487 related articles for article (PubMed ID: 27735143)
21. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
[TBL] [Abstract][Full Text] [Related]
22. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
23. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
24. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
Hanly JG; Su L; Farewell V; Fritzler MJ
J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
Front Immunol; 2019; 10():1026. PubMed ID: 31134086
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
27. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
[TBL] [Abstract][Full Text] [Related]
28. [Thrombocytopenic purpura and hemolytic anemia in children with generalized lupus erythematosus].
Martínez-Cordero E; Vega-Avila E; Negrete-García MC; Zamudio-Cortés P; Aguilar-Frausto I
Bol Med Hosp Infant Mex; 1991 Jul; 48(7):463-8. PubMed ID: 1930714
[TBL] [Abstract][Full Text] [Related]
29. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
[TBL] [Abstract][Full Text] [Related]
30. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
31. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
Jia Y; Zhao L; Wang C; Shang J; Miao Y; Dong Y; Zhao Z
Dis Markers; 2018; 2018():4528547. PubMed ID: 30363714
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
Conti F; Alessandri C; Perricone C; Scrivo R; Rezai S; Ceccarelli F; Spinelli FR; Ortona E; Marianetti M; Mina C; Valesini G
PLoS One; 2012; 7(3):e33824. PubMed ID: 22461897
[TBL] [Abstract][Full Text] [Related]
33. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Abdulahad DA; Westra J; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2011 May; 13(3):R71. PubMed ID: 21548924
[TBL] [Abstract][Full Text] [Related]
34. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
Caccavo D; Rigon A; Picardi A; Galluzzo S; Vadacca M; Ferri GM; Amoroso A; Afeltra A
Clin Rheumatol; 2005 Aug; 24(4):381-7. PubMed ID: 15592902
[TBL] [Abstract][Full Text] [Related]
35. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and serological characteristics of systemic lupus erythematosus: 128 cases].
Ghedira I; Sakly W; Jeddi M
Pathol Biol (Paris); 2002 Feb; 50(1):18-24. PubMed ID: 11873624
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
39. Increased serum RANTES in patients with systemic lupus erythematosus.
Lu MM; Wang J; Pan HF; Chen GM; Li J; Cen H; Feng CC; Ye DQ
Rheumatol Int; 2012 May; 32(5):1231-3. PubMed ID: 21258798
[TBL] [Abstract][Full Text] [Related]
40. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
